MENU
MET
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

MET stock forecast, quote, news & analysis

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products... Show more

A.I.Advisor
published price charts
MET
Daily Signal:
Gain/Loss:
A.I.Advisor
Nov 02, 2026

MetLife (MET) Stock Analysis: Steady Gains Push the Shares Back Above $100

Key Takeaways

  • MetLife (MET) shares closed near $100 in late October, marking a recovery of roughly 6% from levels seen about 30 days earlier.
  • The stock reclaimed the $100 level during the period, reflecting a gradual upward trend rather than a sharp, single-catalyst move.
  • As one of the world's largest insurers, MetLife's performance remains tied to interest rates, investment portfolio returns, and demand across its life, group benefits, and retirement businesses.
  • The advance has been broad-based and measured, consistent with steady sector sentiment rather than extraordinary volatility.
  • Investors continue to watch the company's earnings trajectory, capital deployment, and the broader interest-rate environment as key swing factors.
  • For more detail, explore MetLife's Price Targets, Earnings, and Forecast pages.
  • To see how automated strategies are positioning across the market, visit Tickeron's Trending AI Robots page.

Current Market Snapshot

MetLife, Inc. (MET) traded around the $100 mark as of late October, having climbed approximately 6.2% from the $94.16 closing level recorded roughly 30 days earlier. The move was gradual, with the stock regaining the psychologically significant $100 threshold during the period and holding near that level through the final sessions of the month.

The advance unfolded without the kind of extreme daily swings that typically accompany single-event catalysts. Instead, the shares demonstrated a steady, stair-step recovery, suggesting that incremental buying interest and stable sector sentiment, rather than a one-time headline, supported the trend. On a short-term basis, the stock pulled back modestly from its recent highs but remained within a narrow, constructive range.

MetLife (MET) Business Overview and Competitive Position

MetLife is one of the largest insurance and financial services companies in the world, serving tens of millions of customers across the Americas, Asia, Europe, the Middle East, and Africa. The company operates through several core segments, including Group Benefits, Retirement and Income Solutions, and a global life insurance and employee benefits franchise. Its product set spans life insurance, annuities, dental and vision coverage, disability insurance, and workplace benefits, alongside asset management through MetLife Investment Management.

The company's scale, diversified geographic footprint, and strong brand are central competitive advantages. MetLife's exposure to group benefits and institutional retirement solutions provides relatively stable, recurring revenue streams, while its investment portfolio makes earnings sensitive to interest rates and credit conditions. Investors follow the stock closely because it combines defensive, cash-generative characteristics with cyclical leverage to the interest-rate environment.

Recent Developments Driving MET

Over the past 30 days, MetLife's share price advanced from the mid-$90s back above $100, a recovery that coincided with a generally supportive backdrop for the insurance sector. Insurers with large fixed-income portfolios tend to benefit from firmer yields and favorable spread dynamics, which can improve investment income over time. The stock's steady climb suggests investors weighed these factors alongside the company's capital position and ongoing share-repurchase activity.

The move also reflected a broader rotation of interest toward financial and insurance names, as market participants assessed the outlook for rates and credit quality. MetLife's diversified business model, which includes group benefits and retirement solutions, offered a degree of insulation from more volatile consumer or technology-driven segments. While no single announcement defined the period, the cumulative effect of steady demand, disciplined capital management, and a resilient rate backdrop supported the shares' upward drift.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies drawn from a much larger universe of AI-driven bots. While Tickeron offers hundreds of AI trading bots that collectively monitor thousands of tickers, only the top-performing and most relevant strategies appear in this section. The bots featured here vary widely in their approach, including differences in trading style, holding timeframe, and performance metrics, giving users a snapshot of strategies currently generating attention. The page is designed to help traders and investors explore how algorithmic systems are navigating market conditions in real time. For those interested in automated, data-driven approaches to stock analysis, this section offers a practical starting point for further research.

2026 Outlook and What Investors Should Watch

Looking ahead, several factors are likely to shape MetLife's performance in 2026. The trajectory of interest rates and credit spreads will remain a primary driver, given the company's substantial fixed-income portfolio and the influence of rates on both investment income and annuity demand. Earnings releases and management guidance on group benefits enrollment, retirement solutions flows, and underwriting margins will also be closely monitored.

Investors are likely to watch capital-deployment decisions, including buybacks and dividends, as well as any changes in regulatory or accounting frameworks affecting the insurance industry. Competitive dynamics in workplace benefits and evolving customer preferences for retirement products represent additional themes. Macroeconomic conditions, including inflation trends and labor-market health, could influence both premium growth and claims experience. As always, these factors should be evaluated in the context of an investor's own objectives and risk tolerance rather than as a basis for near-term predictions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for MET with price predictions
Nov 02, 2026

MET sees MACD Histogram crosses below signal line

MET saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 27, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 32 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 60%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 25 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on MET as a result. In 47 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.

MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.

Following a +2.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 28 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.338) is slightly higher than the industry average of (1.339). P/E Ratio (19.190) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

MET is expected to pay dividends on December 08, 2026

MetLife MET Stock Dividends
A quarterly dividend of $0.59 per share will be paid with a record date of December 08, 2026, and an ex-dividend date of November 03, 2026. The last dividend of $0.59 was paid on September 08. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are MetLife (NYSE:MET), Prudential Financial (NYSE:PRU), Lincoln National Corp (NYSE:LNC), Genworth Financial (NYSE:GNW).

Industry description

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Life/Health Insurance Industry is 18.76B. The market cap for tickers in the group ranges from 228.36K to 140.68B. CILJF holds the highest valuation in this group at 140.68B. The lowest valued company is GWGHQ at 228.36K.

High and low price notable news

The average weekly price growth across all stocks in the Life/Health Insurance Industry was 1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -4%. CNO experienced the highest price growth at 8%, while AAME experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Life/Health Insurance Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 91
Profit Risk Rating: 60
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
MET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of insurance and financial services and also function as bank holding company

Industry LifeHealthInsurance

Industry
Life Or Health Insurance
Address
200 Park Avenue
Phone
+1 212 578-9500
Employees
46000
Web
https://www.metlife.com
MetLife (MET) Stock Analysis: Steady Gains Push the Shares Back Above $100